Published in BMC Biotechnol on January 18, 2017
Imaging in the era of molecular oncology. Nature (2008) 11.10
Shedding light onto live molecular targets. Nat Med (2003) 8.47
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Molecular imaging in cancer. Science (2006) 5.01
Optical imaging: current applications and future directions. J Nucl Med (2007) 2.84
A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev (2012) 2.76
Role of Kupffer cells in host defense and liver disease. Liver Int (2006) 2.55
Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev (2005) 2.53
Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol (2002) 1.83
Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo. Nat Commun (2013) 1.66
Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol (2009) 1.64
H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. ACS Chem Biol (2009) 1.56
Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Mol Cancer Ther (2012) 1.48
Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res (2000) 1.35
The use of spinning-disk confocal microscopy for the intravital analysis of platelet dynamics in response to systemic and local inflammation. PLoS One (2011) 1.17
In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. J Control Release (2014) 0.97
Potential of activatable FAP-targeting immunoliposomes in intraoperative imaging of spontaneous metastases. Biomaterials (2016) 0.94
Autofluorescence imaging and the quantitative intensity of fluorescence for evaluating the dysplastic grade of colonic neoplasms. Int J Colorectal Dis (2011) 0.88
Suitable labels for molecular imaging--influence of dye structure and hydrophilicity on the spectroscopic properties of IgG conjugates. Bioconjug Chem (2011) 0.86
Species-crossreactive scFv against the tumor stroma marker "fibroblast activation protein" selected by phage display from an immunized FAP-/- knock-out mouse. Mol Med (2001) 0.84
N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity. PLoS One (2012) 0.82
Liposomal encapsulation of a near-infrared fluorophore enhances fluorescence quenching and reliable whole body optical imaging upon activation in vivo. Small (2013) 0.82
Near-infrared Fluorescence Optical Imaging in Early Rheumatoid Arthritis: A Comparison to Magnetic Resonance Imaging and Ultrasonography. J Rheumatol (2015) 0.82
Intravital imaging - dynamic insights into natural killer T cell biology. Front Immunol (2015) 0.81
The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks? Expert Opin Drug Saf (2006) 0.81
Novel fluorophores as building blocks for optical probes for in vivo near infrared fluorescence (NIRF) imaging. J Fluoresc (2010) 0.80
Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents. Am J Nucl Med Mol Imaging (2014) 0.79
Anniversary paper: nuclear medicine: fifty years and still counting. Med Phys (2008) 0.78
Combined Fluorescence and Magnetic Resonance Imaging of Primary Macrophage Migration to Sites of Acute Inflammation Using Near-Infrared Fluorescent Magnetic Nanoparticles. Mol Imaging Biol (2015) 0.78
Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties. EJNMMI Res (2013) 0.77